Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.5B | 24.7B | 15.7B | 16.0B |
Cost of revenue | 11.7B | 20.7B | 13.2B | 13.8B |
Gross profit | 1.9B | 4.0B | 2.5B | 2.2B |
Operating expense | ||||
Research & development | 673M | 899M | 758M | 850M |
Selling general and admin | 665M | 675M | 602M | 678M |
Other operating expenses | — | — | — | — |
Operating income | 540M | 2.5B | 1.1B | 712M |
Non operating interest income | ||||
Income | 209M | 221M | 183M | 182M |
Expense | 189M | 260M | 212M | 215M |
Other income expense | — | — | — | — |
Pretax income | 1.1B | 2.8B | 1.3B | 510M |
Tax provision | 349M | 420M | 312M | 329M |
Net income | 745M | 2.4B | 938M | 181M |
Basic EPS | 1.0 | — | 1.2 | 0.3 |
Diluted EPS | 1.0 | — | 1.2 | 0.3 |
Basic average shares | 787.4M | — | 792.7M | 793.1M |
Diluted average shares | 788.6M | — | 792.7M | 793.1M |
EBITDA | 1.9B | 4.1B | 2.0B | 1.5B |
Net income from continuing op. | 745M | 2.4B | 938M | 181M |
Minority interests | 48M | 17M | 45M | 49M |
Preferred stock dividends | 0 | 0 | 0 | 0 |